Merck discontinues some cancer drug development with China's Sichuan Kelun

Merck discontinues some cancer drug development with China's Sichuan Kelun

Submitted by admin on October 24, 2023 - 10:00am
Source: 
Reuters
News Tags: 
Merck
Sichuan Kelun Pharmaceutical
cancer
oncology
Headline: 
Merck discontinues some cancer drug development with China's Sichuan Kelun
snippet: 

Chinese drugmaker Sichuan Kelun Pharmaceutical Co (002422.SZ) said on Monday that Merck & Co Inc (MRK.N) was abandoning the joint development of two candidate cancer drugs which have yet to start clinical trials.

Do Not Allow Advertisers to Use My Personal information